fda glp 1 shortage GLP-1 No Longer on FDA's Drug List Taking Stock: What Ro's GLP-1

Additional evidence has indicated that GLP-1RAs elevated circulating irisin levels and BDNF (47, 48)

PMID: 36151309

FDA Crackdown on Compounded GLP-1s (Regulatory): On February 6, 2026, the FDA announced a formal intent to restrict the use of active pharmaceutical ingredients (APIs) for non-approved compounded GLP-1 drugs, targeting "mass-marketed" alternatives from companies like Hims & Hers as the national supply of brand-name versions stabilized

[DOI] [PMC free article] [PubMed] [Google Scholar] 195.Ma, H

In simpler terms, it is a peptidea short chain of amino acids that tells your body how to manage blood sugar and appetite

I could have gotten myself a three-month supply and been able to at least have the ability to figure out what I was going to do, he said, but not having any time and having to scramble for no reason that inability to make those decisions for myself when I am paying my monthly bills to this agency as their respected customer, it felt like an affront. In a statement, IBX said the company began notifying employer groups about the coverage change as early as August